Phase II trial of cetuximab plus docetaxel in patients with relapsed head and neck carcinoma

被引：0
|
作者：
Knoedler, M. [1 ]
Na, I. -K. [1 ]
Rohde, M. [1 ]
Thiel, E. [1 ]
Schmittel, A. [1 ]
Keilholz, U. [1 ]
机构：
[1] Charite Med Klin III, Berlin, Germany
来源：
ONKOLOGIE | 2008年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：110 / 110
页数：1
相关论文
共 50 条
  • [31] Cetuximab and bevacizumab: preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neck
    Argiris, A.
    Kotsakis, A. P.
    Hoang, T.
    Worden, F. P.
    Savvides, P.
    Gibson, M. K.
    Gyanchandani, R.
    Blumenschein, G. R., Jr.
    Chen, H. X.
    Grandis, J. R.
    Harari, P. M.
    Kies, M. S.
    Kim, S.
    ANNALS OF ONCOLOGY, 2013, 24 (01) : 220 - 225
  • [32] Durvalumab with cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: A phase I/II trial
    Bonomo, P.
    Desideri, I.
    Mangoni, M.
    Loi, M.
    Saieva, C.
    Marrazzo, L.
    Talamonti, C.
    Salvatore, G.
    Sottili, M.
    Teriaca, M. A.
    Stocchi, G.
    Cerbai, C.
    Salvestrini, V.
    Ganovelli, M.
    Massi, D.
    Gallo, O.
    Santoro, R.
    Spinelli, G.
    Pallotta, S.
    Livi, L.
    ANNALS OF ONCOLOGY, 2020, 31 : S686 - S686
  • [33] Docetaxel, cisplatin and 5-FU compared with docetaxel, cisplatin and cetuximab as induction chemotherapy in advanced squamous cell carcinoma of the head and neck: Results of a randomised phase II AGMT trial
    Keil, Felix
    Hartl, Maximilian
    Altorjai, Gabriela
    Berghold, Andrea
    Riedl, Regina
    Pecherstorfer, Martin
    Mayrbaeurl, Beate
    De Vries, Alexander
    Schuster, Judith
    Hackl, Jutta
    Fuereder, Thorsten
    Melchardt, Thomas
    Burian, Martin
    Greil, Richard
    EUROPEAN JOURNAL OF CANCER, 2021, 151 : 201 - 210
  • [34] Weekly Docetaxel, Cisplatin, and Cetuximab in Palliative Treatment of Patients with Squamous Cell Carcinoma of the Head and Neck
    Trieu, Vanessa
    Pinto, Harlan
    Riess, Jonathan W.
    Lira, Ruth
    Luciano, Richard
    Coty, Jessie
    Boothroyd, Derek
    Colevas, A. Dimitrios
    ONCOLOGIST, 2018, 23 (07): : 764 - +
  • [35] Phase I study of ribociclib plus cetuximab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
    Seront, E.
    Schmitz, S.
    Rottey, S.
    Henry, S.
    Lonchay, C.
    van Caloen, G.
    Gilain, A.
    Machiels, J-P.
    ANNALS OF ONCOLOGY, 2016, 27
  • [36] Consolidation cetuximab after concurrent triplet radiochemotherapy plus cetuximab in patients with advanced head and neck cancer: A randomized phase II study
    Riesterer, Oliver
    Pruschy, Martin
    Bender, Sabine
    Sharma, Ashish
    Bogowicz, Marta
    Tanadini-Lang, Stephanie
    Stieb, Sonja
    Bertogg, Kaja
    Weber, Sandra
    Ikenberg, Kristian
    Huber, Gerhard
    Schmid, Stephan
    Bredell, Marius
    Veit-Haibach, Patrick
    Rordorf, Tamara
    Held, Ulrike
    Glanzmann, Christoph
    Studer, Gabriela
    RADIOTHERAPY AND ONCOLOGY, 2020, 150 : 62 - 69
  • [37] Phase II randomized trial of surgery followed by chemoradiation plus cetuximab for high-risk squamous cell carcinoma of the head and neck (RTOG 0234)
    Harari, P. M.
    Harris, J.
    Kies, M. S.
    Myers, J. N.
    Machtay, M.
    Rotman, M. Z.
    Khuntia, D.
    Straube, W. L.
    Ang, K. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S13 - S13
  • [38] A phase II trial of palliative docetaxel plus 5-fluorouracil for squamous-cell cancer of the head and neck
    Colevas, AD
    Adak, S
    Amrein, PC
    Barton, JJ
    Costello, R
    Posner, MR
    ANNALS OF ONCOLOGY, 2000, 11 (05) : 535 - 539
  • [39] A MULTICENTER PHASE II TRIAL TO EVALUATE THE COMBINATION OF CETUXIMAB (C) PLUS TPF (DOCETAXEL, CISPLATIN AND FLUOROURACIL) AS INDUCTION CHEMOTHERAPY (IC) FOLLOWED BY CETUXIMAB PLUS ACCELERATED RADIOTHERAPY (RT) WITH CONCOMITANT BOOST IN PATIENTS (PTS) WITH UNRESECTABLE LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF HEAD AND NECK (SCCHN)
    Mesia, R.
    Vazquez, S.
    Grau, J. J.
    Garcia, A.
    Garcia-Giron, C.
    Carles, J.
    Irigoyen, A.
    Lozano, A.
    Manos, M.
    Cruz, J. J.
    ANNALS OF ONCOLOGY, 2010, 21 : 319 - 319
  • [40] Randomised phase II study with cetuximab in combination with 5-FU and cisplatin or carboplatin versus cetuximab in combination with paclitaxel and carboplatin for treatment of patients with relapsed or metastatic squamous cell carcinoma of the head and neck (CETMET trial).
    Friesland, Signe
    Tsakonas, Georgios
    Kristensen, Claus
    Moren, Maria Herlestam Calero
    Haugen, Hedda
    Soderstrom, Karin
    Specht, Lena
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345